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Abstract
Reactive oxygen species (ROS) have been known for a long time to play important roles in host defense against microbial
infections. In addition, it has become apparent that they also perform regulatory roles in signal transduction and cell
proliferation. The source of these chemicals are members of the NOX family of NADPH oxidases that are found in a variety of
tissues. NOX1, an NADPH oxidase homologue that is most abundantly expressed in colon epithelial cells, requires the
regulatory subunits NOXO1 (NOX organizing protein 1) and NOXA1 (NOX activating protein 1), as well as the
flavocytochrome component p22
phox for maximal activity. Unlike NOX2, the phagocytic NADPH oxidase whose activity is
tightly repressed in the resting state, NOX1 produces superoxide constitutively at low levels. These levels can be further
increased in a stimulus-dependent manner, yet the molecular details regulating this activity are not fully understood. Here
we present the first quantitative characterization of the interactions made between the cytosolic regulators NOXO1 and
NOXA1 and membrane-bound p22
phox. Using isothermal titration calorimetry we show that the isolated tandem SH3
domains of NOXO1 bind to p22
phox with high affinity, most likely adopting a superSH3 domain conformation. In contrast,
complex formation is severely inhibited in the presence of the C-terminal tail of NOXO1, suggesting that this region
competes for binding to p22
phox and thereby contributes to the regulation of superoxide production. Furthermore, we
provide data indicating that the molecular details of the interaction between NOXO1 and NOXA1 is significantly different
from that between the homologous proteins of the phagocytic oxidase, suggesting that there are important functional
differences between the two systems. Taken together, this study provides clear evidence that the assembly of the NOX1
oxidase complex can be regulated through reversible protein-protein interactions.
Citation: Dutta S, Rittinger K (2010) Regulation of NOXO1 Activity through Reversible Interactions with p22
phox and NOXA1. PLoS ONE 5(5): e10478. doi:10.1371/
journal.pone.0010478
Editor: Andreas Hofmann, Griffith University, Australia
Received March 9, 2010; Accepted April 12, 2010; Published May 4, 2010
Copyright:  2010 Dutta, Rittinger. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was funded by the Medical Research Council, UK. The funders had no role in study design, data collection and analysis, decision to publish, or
preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: katrin.rittinger@nimr.mrc.ac.uk
¤ Current address: School of Biological Sciences, Nanyang Technological University, Singapore, Singapore
Introduction
Superoxide is generated in a variety of tissues by NADPH
oxidase (NOX) enzymes. It is an intermediate in the formation of
reactive oxygen species (ROS), which have been implicated in a
number of cellular functions including host defence, apoptosis,
signalling and cell proliferation [1–7].
The first member of the NOX protein family to be identified
was the phagocytic NADPH oxidase, whose gp91
phox subunit is
now referred to as NOX2. This enzyme is primarily found in
phagocytes where it plays a fundamental role in host defence
against microbial infections [8–10]. This microbicidal activity was
originally believed to be the main function of ROS. However, the
recent discovery of a number of novel NOX family members in a
diverse range of tissues, which include NOX1-5, Duox1 and
Duox2, indicates that superoxide production by these proteins has
a much wider physiological function [6,7,11–15].
The phagocytic oxidase is still the best characterized member of
this protein family and consists of a heterodimeric flavocytochrome
(containing NOX2 and p22
phox) that makes up the catalytic core of
the enzyme plus the cytosolic regulatory subunits p40
phox, p47
phox
and p67
phox and the small GTPase Rac [8,16–18]. Because
excessive ROS production is cytotoxic and can induce a number
of pathological processes, complicated regulatory mechanisms have
evolved that tightly control the activity of the phagocytic oxidase. In
the resting state, inappropriate activation is prevented through the
partitioning of its subunits between the cytosol (p40
phox, p47
phox,
p67
phox and Rac) and the membrane (NOX2,p22
phox). Theresting,
cytoplasmic location of a trimeric p40-p67-p47
phox complex is
maintained due to an autoinhibitory conformation of p47
phox that
prevents the interaction with the membrane-bound flavocyto-
chrome [18]. Cell activation induces phosphorylation of p47
phox at
a number of serine residues leading to conformational changes and
ultimately relieving autoinhibition. This in turn allows p47
phox to
interact with a consensus PxxP motif within the cytoplasmic portion
of p22
phox, thereby promoting membrane translocation of the p40-
p67-p47
phox complex and assembly of the active NADPH oxidase
enzyme [19–22]. Due to these multiple activities of p47
phox this
subunit plays a key role in NADPH oxidase function, acting
simultaneously as a regulator of oxidase activity and an adaptor
protein promoting enzyme assembly. In the autoinhibited state its
tandem SH3 (Src homology 3) domains are engaged in an
intramolecular interaction with a region rich in basic residues
(polybasic region, also referred to as autoinhibitory region AIR) and
hencearepreventedfrominteractingwithp22
phox[21,23](Figure1).
The crystal structure of the autoinhibited core of p47
phox revealed
PLoS ONE | www.plosone.org 1 May 2010 | Volume 5 | Issue 5 | e10478Figure 1. Schematic representation of the domain structures of p47
phox, NOXO1, p67
phox and NOXA1. (A) Predicted domain structures
of NOXO1 and NOXA1 in comparison to p47
phox and p67
phox, respectively. Human and mouse constructs used in this study are illustrated by black
lines. Mouse constructs are identical in length unless otherwise stated in brackets. The autoinhibitory region (AIR) and proline rich region (PPR) are
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tion, termed the superSH3 domain, in which the two SH3 domains
co-operate to form a single ligand binding site that is occupied by a
non-canonical motif located in the N-terminal portion of the
polybasic region [22,24]. Extensive, additional contacts are made
between the polybasic region and the reminder of p47
phox, outside
of the core superSH3 domain ligand binding site that are important
to enforce the resting state. Multiple serine residues within this
polybasic region become phosphorylated upon activation, a process
that weakens the intramolecular interactions and instead favours
complex formation with the membrane-bound cytochrome.
Additionally, a proline-rich region in the C-terminal portion of
p47
phox mediates the interaction with p67
phox via specific
recognition of its C-terminal SH3 domain. This interaction, which
occurs with an unusually high affinity of 20 nM [25–27], is
absolutely required for translocation of p67
phox to the membrane.
Although NOX1 was the first homologue of the phagocytic
oxidase to be identified, its precise physiological function remains
somewhat controversial although there is support for a role in host
cell defense in the gastrointestinal tract and cell proliferation
[11,28–31]. For optimal activity NOX1 has been shown to require
p22
phox, Rac and two regulatory subunits, termed NOXO1 (NOX
organizing protein 1) and NOXA1 (NOX activating protein 1)
that have been identified based on their homology with p47
phox
and p67
phox, respectively [32–37]. The main difference between
p47
phox and NOXO1 is the absence of the polybasic region that is
important for autoinhibition and the regulation of the interaction
with p22
phox. NOXA1 contains a TPR (tetratricopeptide), PB1
(Phox and Bem1) and a carboxy-terminal SH3 domain, similar to
p67
phox, but lacks a centrally located SH3 domain (Figure 1).
The lack of the autoinhibitory region in NOXO1 combined
with the observations that NOX1 produces superoxide constitu-
tively at low levels and that a stimulus-induced increase in
superoxide production only occurs in certain human cell types,
has led to the suggestion that NOXO1 is permanently associated
with p22
phox and that its activity is not regulated by phosphor-
ylation or other signalling events that may induce changes in
protein-protein interactions as seen for the phagocytic enzyme
[32–34].
This study is aimed at providing the first quantitative
description of the interactions taking place between NOX1
components in order to uncover the underlying mechanisms that
are responsible for the observed stimulus-dependent increase in
superoxide production. In particular we were interested in
determining if the interaction between NOXO1 and p22
phox is
indeed constitutive and if, in the absence of the autoinhibitory
region, there is any need for the tandem SH3 domains to adopt a
superSH3 domain conformation.
Our data clearly indicate that both SH3 domains of NOXO1
are required for the interaction with p22
phox, strongly suggesting
that it will form a superSH3 domain. Importantly though, only
very weak binding was observed between p22
phox and a fragment
of NOXO1 containing the tandem SH3 domains plus the C-
terminal tail, implying that autoinhibitory interactions do indeed
exist within NOXO1. Furthermore, unlike the phagocytic oxidase,
complex formation between NOXO1 and NOXA1 is relatively
weak, indicating that the molecular details of this interaction must
be significantly different from those between p47
phox and p67
phox.
Finally we show that there are differences in the level of
autoinhibition between the human and murine proteins, high-
lighting that the two systems might be regulated by different
mechanisms.
Results and Discussion
NOXO1 forms a superSH3 domain that interacts tightly
with p22
phox
Our first aim was to establish if the tandem SH3 domains of
NOXO1 co-operated in a manner similar to those of p47
phox and
form a superSH3 domain that contains a flexible ligand binding
site for the accommodation of different targets with high affinity
and specificity [22]. Isothermal titration calorimetry (ITC) was
used to measure binding of the individual human or mouse
NOXO1 SH3A and SH3B domains to the p22
phox cytoplasmic
domain. None of these titrations provided any evidence for
complex formation, nor was there any binding between the
isolated SH3 domains themselves (data not shown). This
observation was confirmed using a fluorescently labelled p22
phox-
derived peptide and following changes in fluorescence intensity
upon addition of increasing concentrations of human or mouse
NOXO SH3A and SH3B domains. To ensure that lack of binding
is not due to unfolding of the isolated SH3 domains, their
structural integrity was confirmed by CD spectroscopy (data not
shown). In contrast, the tandem SH3 domains of human and
mouse NOXO1 bound tightly with affinities of 0.15 mM for
human and 0.068 mM for mouse NOXO1 to the cytoplasmic
domains (referred to as p22
phoxC) of human and murine p22
phox,
respectively (Table 1 and Figure 2). These data firmly establish
that the tandem SH3 domains of NOXO1 need to co-operate to
form a single unit that tightly interacts with p22
phox as previously
observed in p47
phox (Kd p47-p22
phox: 0.19 mM, [22]).
In light of this high-affinity interaction between the tandem SH3
domains of NOXO1 and p22
phox it is rather surprising that a
NOXO1 fragment that lacks the PX (PhoX domain) domain is not
capable anymore of co-localizing with NOX1 and p22
phox at the
plasma membrane as described by Cheng and colleagues [38].
This observation implies that the high affinity for p22
phox must be
diminished in the presence of additional sequences outside the
tandem SH3 domains, possibly due to not yet identified
autoinhibitory interactions.
The presence of the C-terminal tail of NOXO1
significantly weakens the interaction with p22
phox
In the resting state, p47
phox is prevented from binding to
p22
phox due to an intramolecular interaction between its tandem
SH3 domains and the autoinhibitory region. This sequence is
absent in human as well as mouse NOXO1 (Figure 1A and B). To
determine if other motifs are present in the C-terminal tail of
NOXO1 that may influence binding of the tandem SH3 domains
to p22
phox, ITC titrations were carried out with constructs
harbouring the tandem SH3 domains plus the C-terminal portion
of NOXO1 (referred to as SH3AB–E). Indeed, the interaction
between human SH3AB–E and p22
phox was weakened over 100-
fold to 17.5 mM in comparison to the tandem SH3 domains
(Figure 3). Interestingly, this inhibitory effect of the C-terminal tail
of NOXO1 is less pronounced in the mouse protein. Nevertheless,
indicated. (B) Alignment of p47
phox, human NOXO1 and mouse NOXO1. The PX domains (grey shaded), SH3 domains (cyan shaded), polybasic region
(orange shaded ox) and proline rich motif (green shaded) are indicated. (C) Structure of the autoinhibited core of p47
phox showing the superSH3
domain conformation. The structure shows the biologically relevant monomeric form of the protein that is also observed in solution, not the domain-
swapped crystallized dimer [22]. The SH3 domains and polybasic region are highlighted in cyan and orange, respectively.
doi:10.1371/journal.pone.0010478.g001
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phox is weakened by around 10-fold
(Kd=0.78 mM)(Figure 3 and Table 1). These results strongly
suggest that autoinhibitory interactions do exist in both NOXO1
isoforms, but are more pronounced in the human protein. These
data are particularly interesting in light of previous studies that
showed that superoxide production by human NOX1 can be
increased by stimulators such as PMA, while a similar increase
could not be observed with the mouse proteins [32–34]. It is
conceivable that the 0.78 mM tight interaction between murine
NOXO1 and p22
phox is strong enough, even in the presence of
inhibitory interactions with the C-terminal tail, to support full
enzymatic activity, while the significantly weaker human complex
(Kd=17.5 mM) requires a conformational change to adopt a fully
active NOXO1-p22
phox complex conformation.
Close examination of the C-terminal tail of human NOXO1
reveals a region comprising a number of basic residues that is
absent in the mouse protein (see Figure 1B) (residues 347–359,
ERRPRRQGRPRG). To test whether this region might contrib-
ute to the stronger autoinhibition in human NOXO1, a peptide
corresponding to this region was synthesized and binding to the
tandem SH3 domains was measured using ITC (data not shown).
However, no binding was detected under the experimental
conditions, suggesting that this is not the region responsible for
the observed differences.
The tandem SH3 domains of NOXO1 are involved in
intramolecular interactions
SH3 domains classically bind to sequences harbouring a
consensus PxxP motif. Such a motif is absent in the region
responsible for autoinhibition in p47
phox but is present in the C-
terminus of the protein. However, in the phagocytic enzyme this
region mediates a very tight interaction with p67
phox.A
homologous motif is found in the C-terminal regions of human
and mouse NOXO1 and is similarly believed to be the target of
the SH3 domain of NOXA1 (Figure 1B)[34,35]. To investigate if
this region might be additionally involved in an intramolecular
interaction with the tandem SH3 domains, a peptide correspond-
ing to amino acids 319–347 of human NOXO1 (peptideA:
TAPPPTVPTRPSPGAIQSRCCTVTRRALE) was titrated
against the tandem SH3 domains as well as against the individual
SH3A and SH3B domains of the human protein. A weak
interaction with the tandem SH3 domains could be detected with
aK d of around 50 mM but not with any of the individual domains
(data not shown). Interestingly this affinity is similar to that
previously measured for the interaction between the isolated PX
and SH3 domains in p47
phox, which are believed to be engaged in
an intramolecular interaction [39], consistent with a potential
regulatory role. To gain further insight into the molecular details
of this intramolecular interaction and to test the potential
involvement of the conserved proline residues, which in the
phagocytic enzyme are recognised by p67
phox, we mutated proline
residues 323, 326 and 329 to alanine in construct SH3AB–E
(human) and tested the ability of this mutant protein to interact
with p22
phox. Indeed, substitution of these proline residues strongly
favoured the interaction with p22
phox, which now occurred with
almost the same affinity to that of the isolated tandem SH3
domains (Kd=0.5 mM)(Table 1). The importance of this region
for autoinhibition is further supported by the titration of the
tandem SH3 domains of NOXO1 with a shorter version of
peptideA, which only contains the proline rich region
(TAPPPTVPTRPS) and was able to bind with a similar affinity
as the long version of peptideA (Kd,50 mM). These results
convincingly show that intramolecular interactions do exist in
NOXO1, which include its tandem SH3 domains and the proline-
rich sequence located C-terminally to it that interfere with the
interaction with p22
phox. Given the sequence conservation within
the SH3 domains and proline-rich regions of human and mouse
NOXO1 we do not understand at present why these autoinhibi-
tory interactions are significantly more pronounced in human
NOX1 and can only speculate that the length of the linker
connecting the tandem SH3 domains and the proline-rich region,
which is shorter in murine NOXO1, may be responsible for the
observed differences.
The interaction between NOXO1 and NOXA1 is weak
A previous study investigating the interaction between NOXO1
and NOXA1 showed that both proteins could be co-immunopri-
cipitated from COS cells [34], which led to the suggestion that
they interacted in a manner similar to p47
phox and p67
phox.
However, the data presented here clearly indicate that the proline-
rich region of NOXO1 is engaged in an intramolecular interaction
with its tandem SH3 domains and hence should not be available to
Table 1. Characterisation of intermolecular interactions between NOXO1 and p22
phox.
Cell component Syringe component Kd (610
26 M) DH (kcal mole
21)T DS (kcal mole
21)
Human NOXO1
SH3AB p22
phoxC 0.1560.01 216.860.06 27.7
SH3AB–E p22
phoxC1 7 . 5 61.0 23.260.6 3.1
SH3AB–E triple mutant p22
phoxC 0.5360.4 28.160.5 20.058
SH3A p22
phoxCN B
SH3B p22
phoxCN B
SH3A SH3B NB
Mouse NOXO1
SH3AB p22
phoxC 0.06860.01 212.960.03 23.3
SH3AB–E p22
phoxC 0.7860.06 27.160.05 20.29
SH3A p22
phoxCN B
SH3B p22
phoxCN B
All measurements were performed at 18uC. The Kd is given in units of 10
26 M, DH and TDS are given in kcal mol
21 (1 kcal/mol;4.184 kJ/mol). The stoichiometry of
complex formation for each binding site is N=1.060.1. No binding is indicated by NB.
doi:10.1371/journal.pone.0010478.t001
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complex formation between these two proteins we measured
binding of the human and mouse NOXA1-SH3 domains to either
NOXO1-SH3AB–E construct by ITC. An interaction took place
between the respective proteins, however, the complexes formed
with .100-fold lower affinities (Kd=7.2 mM for the human and
Kd=2.2 mM for the mouse proteins) than observed for their
phagocytic counterpart (Kd=20 nM, [26])(Figure 4A and
Table 2). To test if this might be due to a competition between
the tandem SH3 domains and NOXA1 for binding to the proline-
rich motif we determined the affinity of either NOXA1-SH3
domain for peptideA (Figure 4B and table 2). Rather unexpect-
edly, the affinity of this peptide for NOXA1-SH3 (human:
Kd=5.8 mM, mouse: Kd=5.9 mM) was not significantly different
from the affinity of the SH3AB–E construct, suggesting that the
intramolecular interaction between the tandem SH3 domains and
the proline-rich region has no influence on the interaction with
NOXA1, which hence must recognize a different region. This
conclusion is further supported by the observation that the short
proline-rich motif-containing version of peptideA binds only with
a very low affinity to NOXA1-SH3 (Kd.70 mM; an exact
determination of this dissociation constant was not possible due
to a low heat change and the low affinity of the interaction). These
observations are in contrast to a study by Yamamoto et al. who
used GST pull-downs to investigate the NOXO1-NOXA1
interaction and found that wild-type NOXO1 failed to bind the
SH3 domain of NOXA1, as suggested due to overlapping
recognition motifs in the proline-rich region [40]. A present the
reason for this discrepancy is not clear and we can only speculate
that under the non-equilibrium conditions of pull-down assays one
of the components may have been washed off.
In the phagocytic oxidase the p47
phox-p67
phox interaction is
unusually strong (Kd of 20 nM) [25,26], due to the presence of two
protein interfaces: contacts are made via the conserved PxxPxR
motif (at amino acids 363–368), but also via an additional surface
composed of residues 369–390 of p47
phox, which fold into a helix-
turn-helix (HTH) motif and pack against b-sheets 2, 3 and 4 of
SH3B p67
phox. Removal of this additional binding motif reduces
the affinity for p67
phox to 20 mM. Based on the data presented in
this manuscript, we now suggest that the interaction between
NOXO1 and NOXA1 relies solely on this additional binding
Figure 3. Characterisation of the interaction between NOXO1
SH3AB–E and p22
phox. Upper part shows the raw calorimetric data for
the interaction of mouse p22
phoxC- NOXO1 SH3AB–E. Lower part shows the
integrated heat changes, corrected for heat of dilution, and fitted to a
single site binding model. (&) Human p22
phoxC titrated into human
NOXO1 SH3AB–E (m) Mouse p22
phoxC titrated into mouse NOXO1 SH3AB–E.
doi:10.1371/journal.pone.0010478.g003
Figure 2. Characterisation of the interaction between the
tandem SH3 domains of NOXO1 and peptides p22
phox. Upper
part shows the raw calorimetric data for the interaction of p22
phoxC and
human NOXO1 SH3AB. Lower part shows the integrated heat changes,
corrected for heat of dilution, and fitted to a single site binding model.
(&) Human p22
phoxC titrated into human NOXO1 SH3AB (m) Mouse
p22
phoxC titrated into mouse NOXO1 SH3AB.
doi:10.1371/journal.pone.0010478.g002
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would be reminiscent of the behaviour of the SH3 domain of
Pex13p, which binds to Pex14 in a conventional fashion via the
recognition of a PxxP motif, while simultaneously interacting, via
an independent surface, with a region in Pex15 that adopts an a-
helical conformation [41,42]. Our model is supported by the fact
that the key residues of p47
phox in the HTH motif that make
contact with p67
phox (I374 and T382) are conserved in human and
murine NOXO1. Structural studies are now required to fully
unravel the details of these interactions.
In this study we provide evidence that the assembly of the
NOX1 oxidase complex can be regulated through reversible
protein-protein interactions. We show that the region C-terminal
to the tandem SH3 domains of NOXO1 interferes with binding to
p22
phox and may thereby prevent the formation of a fully active
oxidase complex in unstimulated cells. However, the inhibitory
effect of the C-terminal tail is less pronounced in NOXO1 than in
the homologous p47
phox subunit of the phagocytic oxidase, and
may explain why the NOX1 system is capable of producing low
levels of superoxide, in a constitutive manner. Based on available
data we propose the following model for the regulation of NOX1
activity: NOXO1 is constitutively associated with NOX1 and
p22
phox at the membrane, however, the complex with p22
phox can
exist in a high and low affinity state. In the resting state a low basal
Figure 4. Characterisation of the interaction between NOXO1 and NOXA1. (A) Upper part shows the raw calorimetric data for the
interaction between human NOXA1 SH3 and NOXO1 SH3AB–E. Lower part shows the integrated heat changes, corrected for heat of dilution, and fitted
to a single site binding model. (&) Human NOXA1 SH3 titrated into human NOXO1 SH3AB–E (m) Mouse NOXA1 SH3 titrated into mouse NOXO1
SH3AB–E.( B) Upper part shows raw calorimetric data for the interaction of peptideA and human NOXA1 SH3. Lower part shows the integrated heat
changes, corrected for heat of dilution, and fitted to a single site binding model. (&) PeptideA titrated into human NOXA1 SH3 (m) PeptideA titrated
into mouse NOXA1 SH3.
doi:10.1371/journal.pone.0010478.g004
Table 2. Characterisation of intermolecular interactions between NOXO1 and NOXA1.
Cell component Syringe component K (610
26 M) DH (kcal mole
21)T DS (kcal mole
21)
Human
NOXO1 SH3AB–E NOXA1 SH3 7.260.5 28.660.7 21.8
NOXA1 SH3 PeptideA 5.860.05 212.660.6 25.6
NOXA1 SH3 PeptideA-short .70
Mouse
NOXO1 SH3AB–E NOXA1 SH3 2.260.05 210.160.8 23.0
NOXA1 SH3 PeptideA 5.960.7 27.660.3 20.64
All measurements were performed at 18uC. The Kd is given in units of 10
26 M, DH and TDS are given in kcal mol
21 (1 kcal/mol;4.184 kJ/mol). The stoichiometry of
complex formation for each binding site is N=1.060.1.
doi:10.1371/journal.pone.0010478.t002
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and this activity is maintained by the low affinity complex between
NOXO1 and p22
phox at the membrane. In this state the affinity of
the tandem SH3 domains for p22
phox would be too low to allow a
constitutive interaction with the membrane-bound cytochrome
and the presence of the PX domain is required to ensure
membrane localization of NOXO1, hence explaining the recent
observation by Cheng and Lambeth that NOXO1 is cytosolic in
the absence of the PX domain [38]. Upon activation with
stimulators such as PMA, NOXO1 becomes fully active and
allows a high affinity interaction with p22
phox, thereby giving rise
to an increase in the level of superoxide production. At present, it
is unclear how cycling of NOXO1 between these two states is
regulated and what the molecular details of this active state are,
but our data suggest that full activation will require disruption of
the intramolecular interaction between the tandem SH3 domains
and the proline-rich region. In the case of the phagocytic oxidase,
it is the phosphorylation of multiple serine residues in the polybasic
region of p47
phox that induces these conformational changes.
Equivalent phosphorylation sites are absent in NOXO1, suggest-
ing that other mechanisms will regulate the interaction with
p22
phox. A recent report by Yamamoto et al. [40] showed that
arachidonic acid could increase the interaction between NOXO1
and p22
phox and it was suggested that this lipid may be a
physiological stimulator. Other scenarios that have not been
investigated yet, such as changes in protein-protein interactions
induced by phosphorylation of NOXA1 or p22
phox [43,44] could
also be envisaged and we cannot rule out the possibility of
involvement of an additional unknown component. Further
studies are now required to shed more light on the regulation of
superoxide production in the NOX1 system.
Materials and Methods
Plasmid construction
Mouse NOXO1 and NOXA1 cDNA were a kind gift from Dr.
B. Banfi (Geneva University Hospital, Geneva, Switzerland),
human NOXO1a and NOXA1 from Dr. T. Leto (National
Institutes of Health, USA) and human p22
phox was from Dr. M. C.
Dinauer (Indiana University School of Medicine, Indiana, USA).
Mouse p22
phox was obtained from Life Technologies Inc
(I.M.AG.E CLONE Id: 5100892). The NOXO1, NOXA1,
p22
phox full length proteins and fragments thereof were cloned
into pGEX-6P1. Mutations were introduced by PCR-mediated
site-directed mutagenesis using the Quikchange kit (Stratagene).
All constructs were sequenced to confirm identities.
Protein overexpression and purification
Proteins were expressed in Escherichia coli strain BL21 STAR
(Invitrogen) (see Figure 1A for complete list of constructs). Cell
cultures were induced at an optical density (A600)o f0 . 8b yt h e
addition of 0.2 mM isopropyl b-D-thiogalactopyranoside and grown
for an additional 3 hours at 28uC. The cells were harvested and the
pellets were stored frozen at 270uC. Cell pellets were thawed in
bufferA (50 mM HEPES, pH 7.4, 150 mM NaCl, 1mM EDTA,
1 mM DDT, with the addition of protease inhibitor tablets (Roche)).
Cell membranes were disrupted by sonication on ice and
supernatants obtained following a 1 hour centrifugation at
48,0006g. Recombinant GST-fusion proteins were purified by
affinity chromatography on glutathione Sepharose 4B, washed with
bufferA plus 500 mM NaCl and cleaved overnight in bufferA with
PreScissionProteasetoremovetheGSTtag(AmershamBiosciences).
Further purification was carried by gel filtration in bufferA on
Superdex 75. The purity and identity of the proteins was confirmed
by SDS/PAGE analysis (12 or 15% gels) and electrospray mass
spectrometry. Synthetic peptides were prepared by P. Fletcher
(NIMR) and Dr. W. J. Mawby (University of Bristol, UK).
Isothermal titration calorimetry
Complex formation between NOXO1, NOXA1 and p22
phox
fragments or peptides were measured by isothermal titration
calorimetry using a MicroCal VP-ITC calorimeter (MicroCal
Inc., Northampton, USA). All proteins were dialysed against ITC
buffer (150 mM NaCl, 1 mM DTT and 50 mM HEPES,
pH 7.4) and performed at 18uC. All peptides were dissolved in
ITC buffer. Typically, 20–40 mM of protein in the cell was
titrated by stepwise injections of a total of 200–300 mM of the
ligand. Heats of dilution were determined by titrating protein or
peptide into ITC buffer and subtracted from the raw ITC data
prior to analysis with the software, Origin version 7.0, assuming a
single-site binding model. Data were averaged over three to five
experiments.
Fluorescence Intensity Titration
Fluorescence titrations were carried out using an ISS PC1
spectrofluorometer. All measurements were carried out at 20uC
with excitation at 492 nm and emission at 525 nm. A solution
containing fluorescein labelled peptide1 (0.5 mM) was prepared in
ITC buffer. Binding measurements were preformed by titrating
increasing concentrations of NOXO1 SH3A or SH3B (1–50 mM)
into this solution.
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